Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01220687 · ClinicalTrials.gov registry record · NA

Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation

A NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
33
Enrollment target
2
Study locations

NCT01220687: Completed NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants, sponsored by University of Oklahoma.

NCT01220687 is a NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants that has completed, run by University of Oklahoma. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01220687, a NA study of Very Low Birth Weight Baby and Respiratory Distress Syndrome in Premature Infants, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
2
Study locations

Study Summary

This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part of supporting baby immediately after delivery, there is more evidence that too much exposure to oxygen may lead to potential problems for your baby later. Oxygen exposure can be harmful to premature babies developing lungs.

Primary Outcome

To investigate whether iNO decreases the supplemental oxygen exposure in the preterm infants who require continuous positive airway pressure (CPAP) or positive pressure ventilation (PPV) during resuscitation as per Neonatal Resuscitation Program (NRP) protocol.

Interventions

  • DRUG iNO
  • OTHER Nitrogen

Study Locations (2)

Oklahoma

  • University of Oklahoma Health Sciences Center - Oklahoma City
  • University of Oklahoma, Childrens Hospital - Oklahoma City

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2011-04
Est. Completion 2017-05-01
Phase NA
University of Oklahoma

358 total trials

What the finished NCT01220687 record still lists

NCT01220687 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Very Low Birth Weight Baby appearing as the primary indexed condition, and to 2 interventions - of which iNO is the first listed.

NCT01220687 reports a single indexed study location in Oklahoma.

Frequently Asked Questions

What is clinical trial NCT01220687 about?

NCT01220687 is a clinical study titled "Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal Resuscitation". This study hopes to determine whether nitric oxide along with oxygen during the first 20 minutes of life in infants needing help with breathing will reduce the percentage and total exposure to oxygen during that time frame. Although the use of oxygen in management of breathing is an important part o...

What is the current status of trial NCT01220687?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-04. Estimated completion is 2017-05-01.

What conditions does trial NCT01220687 study?

This clinical trial studies the following conditions: Very Low Birth Weight Baby, Respiratory Distress Syndrome in Premature Infants.

What interventions are being tested in trial NCT01220687?

The interventions under investigation include: iNO (DRUG), Nitrogen (OTHER).

Who is sponsoring clinical trial NCT01220687?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01220687 being conducted?

This trial has 2 study locations across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Very Low Birth Weight Baby

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01220687's enrollment target sits among peer trials

33 1574th of 2000 higher than 423 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01220687, the US trial registry maintained by the National Library of Medicine. NCT01220687 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.